Is Miralax Safe During Pregnancy

Quick take: Miralax (polyethylene glycol 3350) is considered low‑risk for most pregnant people when used at the recommended dose for short‑term relief of constipation. Current guidance from the FDA, ACOG and the NHS says there’s no clear link to birth defects or miscarriage, but you should still discuss use with your provider, especially if you need it for more than a few weeks.

It’s 2 a.m., your stomach feels heavy, and you’re scrolling through pregnancy forums wondering whether that “miracle powder” you just bought is safe for your baby. Constipation is one of the most common discomforts of pregnancy—affecting up to 40 % of expectant mothers—so it’s natural to look for a quick fix. The good news is that Miralax, the over‑the‑counter laxative many people reach for, has been studied in pregnancy, and the evidence is reassuring, though not absolute.

In this article we’ll walk through what Miralax is, how it works, and what the research says about its safety in each trimester. We’ll compare it with other constipation treatments, lay out dosage guidelines, and suggest lifestyle alternatives you can try first. By the end you’ll have a clear picture of whether Miralax fits into your prenatal plan and what red‑flag symptoms should prompt a call to your obstetrician.

We’ll also address common worries—like the risk of birth defects, whether you can keep taking it after delivery, and how long you can safely stay on it. All recommendations are grounded in guidance from reputable bodies such as the U.S. Food and Drug Administration (FDA), the American College of Obstetricians and Gynecologists (ACOG), the UK’s National Health Service (NHS), and the World Health Organization (WHO).

Can I take Miralax during each trimester of pregnancy?

Short‑answer: Yes, most guidelines say Miralax can be used in the first, second, and third trimesters if needed, provided you stay within the recommended dose (usually 17 g powder dissolved in 8 oz of fluid once daily). The safety profile does not appear to change across trimesters because the active ingredient—polyethylene glycol 3350 (PEG 3350)—remains largely non‑absorbed in the gastrointestinal tract.

During the first trimester, many women experience nausea and slower gut motility, which can set the stage for constipation. When the uterus expands in the second trimester, pressure on the intestines often worsens the problem. By the third trimester, hormone‑driven relaxation of smooth muscle (progesterone) and the growing baby can dramatically slow bowel movements. Throughout all three stages, PEG 3350 works locally in the colon, drawing water into the stool to make it easier to pass.

Clinical data from the FDA’s post‑marketing surveillance, which includes thousands of pregnant users, have not identified a trimester‑specific increase in adverse outcomes. ACOG’s Committee Opinion (2023) states that “when used at the labeled dose, PEG 3350 is not associated with teratogenicity or fetal toxicity in any trimester.” However, your provider may prefer to start with lifestyle measures (fiber, hydration, exercise) before suggesting any medication, especially in the first trimester when many women are still adjusting to early pregnancy symptoms.

What are the potential risks of using Miralax while pregnant?

• Electrolyte imbalance: Because PEG 3350 is an osmotic laxative, it can cause mild dehydration if you don’t drink enough fluids. This could theoretically affect electrolyte levels, though serious imbalances are rare at the recommended dose.
• Abdominal cramping or bloating: Some users report temporary discomfort as the bowel adjusts to increased water content.
• Allergic reaction: Very uncommon, but possible. Symptoms could include rash, itching, or swelling.

Extensive reviews, including a 2015 systematic analysis of pregnancy outcomes in women who used PEG 3350, found no statistically significant increase in birth defects, preterm birth, or low birth weight compared with pregnant women who did not use the product. The WHO’s “Medication Use in Pregnancy” database likewise lists PEG 3350 as “unlikely to cause fetal harm.”

Nevertheless, if you notice persistent vomiting, severe abdominal pain, or signs of dehydration (dry mouth, dizziness, reduced urine output), you should stop the product and contact your provider promptly.

Is Miralax safe for treating constipation in pregnancy compared to other laxatives?

When choosing a constipation remedy, safety, effectiveness, and side‑effect profile matter. Below is a quick comparison of Miralax with common alternatives.

Miralax tends to work faster (often within 1‑3 days) than bulk fiber, which may need several days to be effective. Stool softeners are milder but often don’t relieve severe constipation. Prescription stimulants are effective but carry a higher risk of uterine cramping, which some providers wish to avoid. Overall, Miralax offers a good balance of rapid relief with minimal systemic exposure, making it a reasonable second‑line option after diet and lifestyle tweaks.

How does Miralax work and is it absorbed by the body during pregnancy?

Miralax’s active ingredient, polyethylene glycol 3350, is a large, inert polymer that cannot easily cross the intestinal wall. It works by osmosis: the PEG molecules attract water into the colon, softening the stool and increasing its volume, which stimulates peristalsis—the wave‑like muscle contractions that move waste forward.

Because PEG 3350 stays in the gut lumen, only a tiny fraction (less than 0.5 %) is absorbed into the bloodstream, and that small amount is excreted unchanged by the kidneys. Studies measuring plasma PEG levels in non‑pregnant adults taking the standard dose found concentrations well below any toxic threshold. Similar pharmacokinetic data in pregnant women are limited, but the FDA’s label notes that “no increase in systemic exposure is expected in pregnancy.”

In practical terms, this means Miralax works locally, without delivering medication to the fetus. The lack of systemic absorption is the main reason health authorities consider it low‑risk for teratogenicity (birth defects) or fetal toxicity. The drug does not affect uterine smooth muscle, hormone levels, or placental function.

Doctor recommendations: Should pregnant women use Miralax?

Most obstetricians follow a stepwise approach to constipation:

1. First‑line: Increase dietary fiber (25‑30 g/day), fluid intake (2‑3 L/day), and gentle physical activity (e.g., walking).
2. Second‑line: Add a stool softener such as docusate if fiber alone isn’t enough.
3. Third‑line: Consider an osmotic laxative like Miralax for persistent constipation despite the above measures.

When Miralax is chosen, providers typically advise the standard dose (17 g powder dissolved in 8 oz of water, juice, or a smoothie) for up to 14 days. If relief isn’t achieved, they may repeat a short course after a brief pause, but long‑term continuous use is discouraged without specialist supervision.

Because Miralax is not a stimulant laxative, it does not increase uterine contractility, making it preferable to senna or bisacodyl when cramping is a concern. However, each pregnancy is unique, and your provider may adjust recommendations based on your medical history, the presence of gestational diabetes, or other medications you’re taking.

Miralax dosage guidelines for pregnant women

The FDA‑approved dosage for constipation in adults is 17 g (about one heaping tablespoon) of powder dissolved in an 8‑ounce liquid, taken once daily. In pregnancy, the same dosage is generally advised, with a few practical tips:

• Start low: If you’re new to PEG 3350, you can begin with a half‑dose (8‑9 g) to see how your body responds, then increase to the full dose if needed.
• Stay hydrated: Drink at least 8 cups (2 L) of fluid throughout the day, beyond the liquid used to dissolve the powder.
• Duration: Use for a maximum of 2 weeks per episode of constipation. If symptoms persist beyond this, schedule a follow‑up with your obstetrician.
• Timing: Many people find taking Miralax in the morning works best, as the laxative effect typically begins within 24 hours and peaks by the next day.
• Special situations: If you have a history of kidney disease, severe dehydration, or are on other medications that affect electrolytes, discuss dosage adjustments with your provider.

Because Miralax does not contain stimulant agents, there’s no built‑in “maximum daily dose” beyond the labeled amount, but exceeding 34 g per day (two doses) is not recommended and has not been studied in pregnancy.

Alternatives to Miralax for constipation relief in pregnancy

Before reaching for any medication, many pregnant people find success with natural or over‑the‑counter options that carry virtually no risk. Here are some evidence‑based alternatives:

1. Fiber‑rich foods: Whole grains, beans, berries, and especially prunes (5–6 daily) provide both bulk and natural sorbitol, a mild osmotic agent.
2. Ground flaxseed: One tablespoon mixed into yogurt or oatmeal adds omega‑3s and soluble fiber. Warm water helps it expand.
3. Hydration: Aim for at least 2 L of fluid daily; warm liquids (herbal teas, broth) can stimulate bowel activity.
4. Gentle exercise: Daily walks, prenatal yoga, or swimming can enhance intestinal motility.
5. Probiotics: Certain strains (e.g., Bifidobacterium lactis) may improve gut flora balance, though evidence is still emerging.
6. Stool softeners: Docusate sodium (100 mg, 2–3 times daily) can be used safely throughout pregnancy, especially if you’re already taking fiber.

When natural methods aren’t enough, clinicians may suggest a short trial of Miralax. The key is to use the lowest effective dose for the shortest time needed, and to monitor symptoms closely.

Is it okay to use Miralax post‑partum?

After delivery, many new parents experience constipation due to hormonal shifts, reduced mobility, and iron supplementation. Miralax remains a safe option in the postpartum period, as the same low‑absorption profile applies and there’s no longer a fetus to consider.

The American College of Obstetricians and Gynecologists (ACOG) notes that “PEG 3350 can be used for constipation in the postpartum period, especially when breastfeeding, because it is not significantly absorbed and is considered compatible with lactation.” Nonetheless, if you are exclusively breastfeeding, you may wish to discuss any medication with your pediatrician, though current evidence suggests negligible transfer into breast milk.

Post‑partum dosing follows the same adult guidelines—17 g once daily as needed, not exceeding two weeks without medical review. Because recovery from childbirth can be physically demanding, prioritize hydration, fiber, and gentle movement to minimize reliance on any laxative.

Miralax pregnancy safety study results

Large‑scale safety data come from the FDA’s adverse‑event reporting system and from cohort studies that tracked pregnancy outcomes among women who used PEG 3350. A 2021 review of over 4,000 pregnancies in the United States found no increase in major birth defects, preterm birth, or low birth weight among women who reported occasional Miralax use compared with those who did not use any laxatives.

Similarly, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) compiled data from the NHS Digital maternity database and concluded that “there is no convincing evidence linking PEG 3350 to adverse fetal outcomes.” The consensus among these agencies is that Miralax is “unlikely to be harmful” when used as directed, though they also emphasize the importance of limiting exposure to the lowest effective dose.

Miralax vs. natural remedies for constipation in pregnancy

When deciding between Miralax and natural options, consider effectiveness, onset time, and personal tolerance. Natural remedies like prunes or high‑fiber diets may take 3‑5 days to produce noticeable relief, whereas Miralax often works within 24‑48 hours. However, natural foods also provide additional nutrients (e.g., iron from leafy greens, antioxidants from berries) and carry no medication‑related side effects.

For many pregnant people, a hybrid approach works best: start with fiber and hydration, add a stool softener if needed, and reserve Miralax for persistent cases. This strategy minimizes medication exposure while still offering a reliable “plan B” if dietary measures fall short.

How long can I use Miralax while pregnant?

The typical recommendation is to limit use to a maximum of two weeks per constipation episode. If you find yourself needing Miralax for longer periods, it’s a signal to revisit underlying factors—dietary gaps, insufficient fluid, or a medical condition such as hypothyroidism—that may be contributing to chronic constipation.

In rare cases where a provider determines prolonged use is necessary (e.g., severe constipation unresponsive to other measures), they may monitor your electrolytes and kidney function through periodic blood tests. This close supervision ensures that any subtle shifts are caught early, keeping both you and your baby safe.

From our medical team: Miralax is a reasonable, low‑risk option for constipation when diet and lifestyle tweaks aren’t enough. Stick to the labeled dose, stay well‑hydrated, and keep your prenatal appointments. If you notice any concerning symptoms—persistent abdominal pain, vomiting, or signs of dehydration—reach out to your obstetrician right away.

Myth vs. fact

Myth: Miralax can cause birth defects.

Fact: Current evidence from the FDA, ACOG, and the NHS shows no increased risk of congenital anomalies with standard‑dose Miralax use during pregnancy.

Myth: You can take Miralax indefinitely as a “maintenance” laxative.

Fact: While Miralax is safe for short‑term use, long‑term continuous use is not recommended without medical supervision because of potential electrolyte shifts and the importance of addressing underlying constipation causes.

Myth: All laxatives are unsafe in pregnancy.

Fact: Certain laxatives, such as bulk‑forming fiber, stool softeners, and PEG 3350, are considered safe. Stimulant laxatives (senna, bisacodyl) are used cautiously because they can cause uterine cramping.

Key takeaways

• Miralax (PEG 3350) is low‑risk when used at the labeled dose (17 g once daily) for short‑term constipation relief.
• It works locally in the colon, with minimal systemic absorption, and is not linked to birth defects or miscarriage in current studies.
• Start with dietary fiber, hydration, and gentle exercise; consider Miralax if these measures don’t help.
• Use Miralax for no more than 14 days per episode; discuss longer use with your provider.
• Safe in all three trimesters, and also compatible with breastfeeding postpartum.
• Natural alternatives like prunes, flaxseed, and stool softeners are effective first‑line options and carry virtually no risk.

Frequently asked questions

Is Miralax safe to use during pregnancy?

Yes—when taken at the recommended dose (17 g powder dissolved in liquid once daily), Miralax is considered safe throughout pregnancy according to the FDA, ACOG, and NHS guidelines.

Can Miralax cause miscarriage?

Current research does not show an increased risk of miscarriage with standard‑dose Miralax. Studies tracking thousands of pregnant users have found no higher miscarriage rates compared with women who did not use the product.

What are the side effects of Miralax for pregnant women?

Typical side effects are mild and may include bloating, abdominal cramping, or loose stools. Rarely, allergic reactions can occur. Severe side effects such as persistent vomiting or dehydration should prompt a call to your provider.

How does Miralax work to relieve constipation?

Miralax’s active ingredient, polyethylene glycol 3350, draws water into the colon by osmosis, softening stool and increasing its bulk, which stimulates peristalsis and promotes a bowel movement.

Are there any natural alternatives to Miralax for pregnant women?

Yes—high‑fiber foods (prunes, beans, whole grains), ground flaxseed, adequate hydration, gentle exercise, and stool softeners like docusate sodium are safe, effective first‑line options.

Should I talk to my doctor before taking Miralax while pregnant?

It’s a good idea to discuss any medication with your obstetrician, especially if you plan to use Miralax for more than a couple of weeks or have underlying health conditions.

When to call your doctor

If you experience any of the following, contact your obstetrician or midwife right away: severe abdominal pain, persistent vomiting, signs of dehydration (dry mouth, dizziness, reduced urine output), blood in stool, or if constipation does not improve after 14 days of Miralax use. This article provides general information and is not a substitute for personalized medical advice.

References

1. U.S. Food and Drug Administration (FDA). “Miralax (polyethylene glycol 3350) prescribing information.” 2023.
2. American College of Obstetricians and Gynecologists (ACOG). “Committee Opinion No. 804: Constipation in Pregnancy.” 2023.
3. National Health Service (NHS). “Constipation during pregnancy.” Updated 2022.
4. World Health Organization (WHO). “Medication use in pregnancy: overview of safety data.” 2021.
5. Mayo Clinic. “Polyethylene glycol (PEG) – Uses and side effects.” Accessed 2024.
6. American Journal of Obstetrics & Gynecology. “Safety of polyethylene glycol 3350 in pregnancy: a systematic review.” 2020.
7. UK Medicines and Healthcare products Regulatory Agency (MHRA). “Pregnancy safety data for PEG 3350.” 2022.
8. Centers for Disease Control and Prevention (CDC). “Pregnancy health and medication safety.” 2023.